Lifecycle Management
Post-Market & Real-World Evidence
After approval, programs shift from trial control to real-world complexity. Biology meets daily practice. Algorithms evolve. Evidence must now adapt to real patients and real settings. This stage demands continuous learning.
What companies need at this stage
Teams need real-world biomarker validation, ongoing model refinement, and pipelines that can accomodate new data without losing traceability.
BioLizard solutions
- Continuous AI model retraining with updated clinical inputs.
- Real-world evidence integration with omics data.
- Diagnostic and algorithm refinement using multi-modal signals.
- Cloud architectures built for commercial scale.
Relevant Bio|Verse® modules
Bio|Verse® supports continuous learning loops, audit trails, and modular updates without disruptingproduction systems.
Explore →
Modular offerings
RWE integration packages | Diagnostic refinement modules | Ongoing model monitoring | Cloud maintenance and pipeline evolution
Explore all solutions →
Exploring target expression and identifying other indications with a similar mode of action
The client wanted to study the expression of their target gene within two known indications and to uncover other diseases where the target has a similar mode of action. Identifying comparable indications could strengthen the business case for further development. Our...
Identifying virulence factors in an opportunistic pathogenic bacterium
The client wanted to confirm and identify virulence factors in a gut bacterium that normally resides harmlessly in animals but can cause infection under stress or immunosuppression. Population structure complicated the distinction between pathogenic and commensal...
Unlocking immunogenicity insights from clinical reports with NLP
Most information about the immunogenicity of therapeutic peptides is locked in unstructured clinical reports. The client wanted to extract and structure this data to inform development of safe and effective treatments. Our Approach We built a robust extraction...